Results 221 to 230 of about 156,971 (327)

Acetazolamide for Idiopathic Intracranial Hypertension: An Up-to-Date Review in 2025. [PDF]

open access: yesEye Brain
Naqvi J   +6 more
europepmc   +1 more source

Effects of Yoga Nidra on Stress, Anxiety, and Depression: A Systematic Review and Meta‐Analysis

open access: yesAnnals of the New York Academy of Sciences, EarlyView.
ABSTRACT The global mental health crisis has escalated to unprecedented levels, with stress, anxiety, and depression posing major public health concerns. Conventional interventions have shown limited success in addressing these multifaceted issues, prompting researchers to explore alternative solutions.
Shashank Ghai, Pawel Odyniec, Ishan Ghai
wiley   +1 more source

A Prospective Multicenter Study on the Evaluation of Frequency of Idiopathic Intracranial Hypertension in Korea. [PDF]

open access: yesJ Korean Med Sci
Kim BS   +13 more
europepmc   +1 more source

KRAS Footprints in the Skin: Leveraging Targeted Therapy for Unresectable Intra‐Cerebral AVM

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT A 15‐year‐old female with a longstanding, unresectable intracerebral arteriovenous malformation (AVM) involving the bilateral thalami and basal ganglia presented with progressive neurologic decline. Given the inaccessibility of the intracranial lesion, a lipomatous scalp nodule overlying the AVM was biopsied for molecular testing and revealed ...
Donglin Zhang   +5 more
wiley   +1 more source

Outcomes of Stenting in Atypical Idiopathic Intracranial Hypertension Patients With Transverse Sinus Stenosis [PDF]

open access: gold
Shuang Song   +10 more
openalex   +1 more source

Tocilizumab provides a potential therapeutic option for the management of hyperhaemolysis syndrome in sickle cell disease: A case series and brief narrative overview of the literature

open access: yesTransfusion Medicine, EarlyView.
Abstract Background and Objectives Hyperhaemolysis syndrome is a life‐threatening complication of transfusion, potentially triggered by macrophage activation, with limited treatment options. Tocilizumab, an anti‐IL6 monoclonal antibody, has mechanistic rationale for use and has been shown to be effective in a small number of cases.
S. Wolf   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy